Over a decade of successful treatment with tocilizumab in a maintenance hemodialysis patient for Castleman disease: a case report and literature review
Abstract Background Castleman disease (CD) is a rare, non-neoplastic lymphoproliferative disorder with characteristic histopathological features in lymph nodes. The clinical presentation of CD is highly variable, which can complicate both diagnosis and treatment. Tocilizumab, an interleukin-6 recept...
Saved in:
| Main Authors: | Aya Shima, Takahiro Shima, Chie Matsuo, Takaichi Suehiro, Tomohiko Kamimura, Hiroaki Niiro, Makoto Hirakawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Renal Replacement Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41100-025-00607-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful tocilizumab monotherapy for multicentric Castleman disease complicated by rheumatoid arthritis and Sjögren’s disease: a case-based literature review
by: Koji Suzuki, et al.
Published: (2025-07-01) -
Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
by: Yasuaki Tomioka, et al.
Published: (2021-09-01) -
Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease
by: E. M. Zeltyn-Abramov, et al.
Published: (2021-02-01) -
Castleman's disease in an adolescent
by: Ujjwala Singh, et al.
Published: (2020-01-01) -
A rare case of intracranial Castleman disease
by: K. A. Sulin, et al.
Published: (2023-06-01)